WO2014169542A1 - 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法 - Google Patents

防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法 Download PDF

Info

Publication number
WO2014169542A1
WO2014169542A1 PCT/CN2013/079981 CN2013079981W WO2014169542A1 WO 2014169542 A1 WO2014169542 A1 WO 2014169542A1 CN 2013079981 W CN2013079981 W CN 2013079981W WO 2014169542 A1 WO2014169542 A1 WO 2014169542A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
parts
veterinary drug
preparation
astragalus
Prior art date
Application number
PCT/CN2013/079981
Other languages
English (en)
French (fr)
Inventor
李英伦
房春林
叶刚
何晓利
吕程
靳如文
Original Assignee
四川农业大学
成都乾坤动物药业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 四川农业大学, 成都乾坤动物药业有限公司 filed Critical 四川农业大学
Publication of WO2014169542A1 publication Critical patent/WO2014169542A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Definitions

  • the invention relates to a veterinary drug composition, a preparation and a preparation method thereof, in particular to a veterinary drug composition, a preparation and a preparation method thereof for preventing and treating mycotoxin poisoning.
  • Molds are a general term for filamentous fungi. They often form branched mycelium, but do not produce large fruiting bodies like mushrooms. They can be roughly classified into Asperquillus and Penicillium by attributes. , Fusarum, etc.
  • Mycotoxins are metabolites produced by the growth and reproduction of molds on grains, food and feed, such as Fusarium toxin and aflatoxin. Mycotoxins are usually small molecules, usually have a molecular weight of several hundred to several thousand Daltons, and are not resistant. They are heat-stable substances and are not damaged by simple heating, which often causes molds in livestock or humans. Toxin poisoning.
  • a mold can produce a variety of mycotoxins, and the same mycotoxins can also be produced by several molds. So far, dozens of mycotoxins that are recognized as harmful to livestock and human health have been isolated; aflatoxins (AF), which are common in feed products and cause serious damage to the breeding industry, have aflatoxins (AF). , trichothecenes (including vomiting toxins and T-2 toxins), zearalenone (ZEN), ochratoxin A (ochratoxin, OT), fumonisins (FUM) and Ergotoxin (ERG) and the like.
  • aflatoxins AF
  • trichothecenes including vomiting toxins and T-2 toxins
  • ZEN zearalenone
  • ochratoxin A ochratoxin, OT
  • FUM fumonisins
  • Ergotoxin Ergotoxin
  • mycotoxins are ubiquitous in feed and feed raw materials, which often cause serious harm to livestock and poultry farming and human health, and bring huge economic losses. Since the intake of feed by livestock and poultry is continuous during the livestock and poultry breeding process, the mycotoxin will be continuously accumulated, even if the mycotoxin in the single weight feed is only a trace component, but through one The accumulation of time can also achieve disease or lethal dose.
  • the conventional method for removing mycotoxins in animal feed generally uses a conventional mycotoxin adsorbent or a biological fungicide; although the former adsorbs part of the mycotoxin, it also adsorbs nutrients in the feed; The latter biological fungicide is difficult to be promoted due to its poor stability, heat resistance and acid resistance.
  • the traditional Chinese medicine compound for preventing and treating mycotoxin poisoning is generally a traditional Chinese medicine composition which adopts liver protection and has a recovery effect on liver function, and the control mechanism thereof is: the mold which is absorbed by livestock and poultry and absorbed by the livestock and poultry into the blood.
  • the toxin is combined, and then the toxin is transported to the liver for detoxification and then excreted; the traditional Chinese medicine compound can remove the mycotoxin absorbed into the body, and the medicinal component can also effectively prevent liver damage caused by mycotoxins and the like.
  • Aflatoxin is one of the most important causes of mycotoxin infection in livestock and poultry. Its toxicity is often greater than other mycotoxins. At the same time, the mechanism of aflatoxin pathogenesis is to directly cause pathological damage to the liver of livestock and poultry. It is characterized by decreased growth performance, decreased digestion, elevated liver enzyme index, elevated oxidative stress, etc., and may even lead to cirrhosis or liver cancer. Therefore, the threat of aflatoxin to livestock and poultry farming is greater than other mycotoxins. Summary of the invention
  • the present invention provides a veterinary drug composition for controlling mycotoxins, which can effectively improve or reverse the pathological damage caused by mycotoxin poisoning, reduce the mortality after the mycotoxin of the animal, thereby effectively preventing and controlling the mycotoxin poisoning of the animal.
  • the technical solution of the present invention is to use a veterinary drug composition for controlling mycotoxin poisoning, wherein the veterinary drug composition for controlling mycotoxins is prepared from the following Chinese medicinal materials, and the raw materials are in parts by weight. :
  • the veterinary drug composition for controlling mycotoxins is prepared from the following Chinese medicinal materials, and the raw materials are in parts by weight:
  • the technical solution adopted by the present invention is a veterinary drug composition for controlling mycotoxin poisoning, which is prepared from the following Chinese medicinal materials, and the raw materials are in parts by weight:
  • the invention mainly adopts the above five kinds of Chinese medicinal materials as raw materials to prepare a veterinary drug composition for controlling mycotoxins, and the main raw materials of the traditional Chinese medicines are Bupleurum, Astragalus, Astragalus, Alisma and Schisandra.
  • the present inventors have conducted research on a large number of Chinese medicinal materials, and found that the composition of the traditional Chinese medicine raw materials and the content prepared by the present invention can well control the mycotoxin poisoning of animals. Like, especially the aflatoxin poisoning phenomenon.
  • the traditional Chinese medicine used in the present invention Bupleurum, into the liver and gallbladder, sexually good and ventilated; jaundice, into the gallbladder, longer than heat and dampness; Alisma, Lee water seepage; Astragalus, Yiqi Jianpi; Schisandra, Convergence of sweat and fine.
  • the composition prepared by the five traditional Chinese medicine raw materials can obviously prevent and cure the animal mycotoxin poisoning phenomenon (the actual effect can be referred to the following specific embodiment).
  • the veterinary drug composition for preventing and treating mycotoxins is preferably prepared from the following Chinese medicinal materials, and each Chinese medicinal material is in parts by weight:
  • a second object of the present invention is to provide a use of the aforementioned veterinary composition for the preparation of a medicament for preventing or treating mycotoxin poisoning in livestock and poultry.
  • the aforementioned veterinary drug composition of the present invention can be used for preparing a medicine for preventing or treating mycotoxin poisoning of livestock and poultry, and the medicine belongs to a veterinary medicine. It can be known from the specific examples below that the veterinary medicine composition of the present invention is for preventing or treating livestock and poultry Mycotoxin poisoning has a good pharmacological effect.
  • Aflatoxin is currently the leading cause of mycotoxin poisoning in livestock and poultry, and it can be known from the Examples section below that the veterinary drug composition of the present invention is superior to other mycotoxins in the preparation of medicines for the control of aflatoxin poisoning. Pharmacodynamic data.
  • a third object of the present invention is to provide a veterinary drug preparation for controlling mycotoxin poisoning, which comprises the veterinary drug composition of any of the foregoing.
  • the preparation method can be carried out by a conventional method of the existing traditional Chinese medicine veterinary drug preparation, and at the same time, the dosage form can also be a conventional preparation of the existing veterinary drug preparation.
  • the present invention preferably adopts the dosage form of the veterinary drug preparation as a granule.
  • the granule preparation not only has the characteristics of large dispersity, rapid absorption, mild action and low toxic and side effects of the traditional Chinese medicine oral liquid, and its drug stability is high.
  • the granule preparation can be mixed with water or mixed with animal feed during use to facilitate large-scale farm population administration. Further, the granule preparation is convenient for production and storage as compared with the oral liquid; therefore, it is preferred in the present invention that the veterinary preparation has a dosage form of granules.
  • a fourth object of the present invention is to provide a method for preparing a veterinary drug preparation for preventing and treating mycotoxins, which comprises the following steps:
  • the present invention adopts the above steps to prepare a veterinary drug preparation in which the dosage form is a granule.
  • the above preparation method can effectively and fully extract the medicinal ingredient in each Chinese medicinal material for the obtained veterinary drug preparation, thereby improving the medicinal effect of the preparation.
  • the percolating solution is obtained by a percolation method in a conventional extraction of a traditional Chinese medicine, and the solvent is ethanol. Further, the present invention preferably adopts the step 1) boiling in two steps, each time 0.8-lh, and after filtering, the filtrate is combined twice to obtain a decoction.
  • the present invention preferably employs the step 2) in which the diarrhea is soaked with 75% ethanol. Further, the present invention preferably adopts the preparation method comprising the following steps:
  • each of the comparative examples 1-13 was prepared according to the following preparation method for the corresponding veterinary drug composition for controlling mycotoxin poisoning, and the steps of each preparation method were as follows:
  • the resulting extract is mixed with sugar at a volume/mass ratio of 1:3-4, sieved, and dried to obtain the mycotoxin preparation for controlling mycotoxins, and the preparation is in the form of a granule.
  • the resulting extract is mixed with sugar at a volume/mass ratio of 1:4, sieved, and dried to obtain the mycotoxin preparation for controlling mycotoxins, and the preparation is in the form of a granule.
  • Example 1 Efficacy test of veterinary drug composition of Comparative Example 1-10 prepared according to method (1)
  • Table 1 Test basic diet composition and nutritional indicators
  • Multidimensional elements 1500 IU vitamin A, 200 IU vitamin D3, 10 mg vitamin E, 0.5 mg vitamin K, 4 mg vitamin Bz, lO mg d-pantothenic acid, 25 mg vitamin B6, 25 mg niacin, 800 mg choline chloride, 0.15 mg biotin, 60 mg Mn, 40 mg Zn, 80 mg Fe, 8.0 mg Cu, 0.35 mgl, 0.15 mg Seitati
  • T12 group 8-27 days old were fed with diet (without aflatoxin B1) and T12 group as blank control group;
  • T1-T10 group 8-21 days old, using the ochratoxin A 50 g/kg base stone for uniform feeding, 22 ⁇ -27 ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
  • Group T 11 8-21 days old using ochratoxin A 5 ( ⁇ g/kg of the base stone for uniform feeding, 22 days -27 days old only changed to the base stone diet (excluding ochratoxin A) ) feeding.
  • T1-T12 groups were routinely vaccinated with vaccines such as chicken plague, chicken viral hepatitis, and avian influenza. Use ground level, free access to food and drinking water, 24h light, test period 27d (l ⁇ 27 ⁇ age).
  • Ochratoxin A was produced using Aspergillus sp. 2471 (CICC number, purchased from China) Industrial Microbial Culture Collection) Fermented according to the method of Marquardt et al. Ochratoxin A in corn and diet was determined by high performance liquid chromatography.
  • GPT Alanine aminotransferase
  • GAT aspartate aminotransferase
  • ADP alkaline phosphatase
  • GST glutathione-S transferase
  • SOD superoxide dismutase
  • GSH-PX glutathione peroxidase
  • MDA malondialdehyde
  • Example 2 The experimental method and procedure of Example 2 were the same as those in Example 1. Only the experimental toxin was replaced with aflatoxin B1, and the experimental object was replaced with Cherry Valley commercial meat duck, which was purchased from Sichuan Mianyang Cherry Valley Duck Seed Company, thereby performing the same medicine. Efficiency test, each experimental group is labeled as 2- ⁇ 1
  • the experimental group of the obtained veterinary drug preparation was the same as the 1-T1 1-T10; 2- ⁇ 8 in the first embodiment, and the feeding method was the same as that in the first example, 1- ⁇ 12, 2- ⁇ 9 was poisoned experimental group.
  • the feeding method is the same as 1- ⁇ 11 in Example 1.
  • Aflatoxin was produced by fermentation of Aspergillus flavus 2219 (CICC number, purchased from China Industrial Microbial Culture Collection) by Odette L. Shotwell et al. Aflatoxin B 1 in corn and diet was determined by high performance liquid chromatography.
  • the veterinary drug preparation prepared according to the preparation method (2) according to the preparation method (2) is more effective than the control in the test results of controlling the mycotoxin-aflatoxin.
  • Example 3 The efficacy test of the veterinary drug preparations of Comparative Examples 7, 9, 11, and 13 prepared by the method (3)
  • Example 3 The experimental method and procedure of Example 3 were the same as those in Example 1.
  • the experimental toxins were respectively set to aflatoxin B1 and ochratoxin A, and the experimental objects were replaced with cherry valley commercial meat ducks, which were purchased from Sichuan Mianyang Cherry Valley Duck Seed Industry Co., Ltd.
  • the same efficacy test was carried out; each experimental group was labeled as aflatoxin B1 experimental group: 3- ⁇ 1, 3- ⁇ 2, 3- ⁇ 3, 3- ⁇ 4, 3- ⁇ 5, 3- ⁇ 6 and ochratoxin ⁇ experiment Group: 4- ⁇ 1, 4- ⁇ 2, 4- ⁇ 3, 4- ⁇ 4, 4- ⁇ 5, 4- ⁇ 6; wherein 3-T1 3- ⁇ 4 and 4-T1 4-T4 are respectively used in Comparative Examples 7, 9, 11,
  • 1-T1 1-T10; 3-T5 and 4-T5 are blank control groups, and the feeding method is the same as that of 1-T12; 3-T6 and 4-T6 in Example 1 is a poisoning experimental group, and the feeding method is the same as that in the first embodiment.
  • 1-T11 in the middle The measured results are as follows:
  • Ochratoxin A experimental group Table 6 - Alanine aminotransferase assay data
  • the same vertical shoulder mark * indicates a significant difference (PO.05) compared with the 4-T6 group; the same vertical shoulder mark ** indicates a significant difference (PO.01) compared with the 4-T6 group.
  • the veterinary drug composition and the veterinary drug preparation of the present invention are superior to other mycotoxins in controlling the aflatoxin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

一种防治霉菌毒素中毒的兽药组合物、制剂及其制备方法。所述防治霉菌毒素中毒的兽药组合物由下述中药材制备而成,各原料按重量份数计:柴胡5-8重量份;黄芩3-6重量份;黄芪4-7重量份;泽泻5-8重量份;和五味子4-6重量份。所述防治霉菌毒素中毒的兽药组合物可以有效改善或逆转动物霉菌毒素中毒引起的病理损伤,降低动物霉菌毒素后的死亡率,从而起到有效防治动物霉菌毒素中毒的作用。

Description

防治霉菌毒素中毒的兽药组合物、 应用、 制剂及制备方法
本申请要求于 2013年 04 月 18 日提交中国专利局、 申请号为 201310136059.9、 发明名称为"防治霉菌毒素中毒的兽药组合物、 应 用、 制剂及制备方法"的中国专利申请的优先权, 其全部内容通过引 用结合在本申请中。
技术领域
本发明涉及一种兽药组合物、制剂及其制备方法, 具体涉及一种 防治霉菌毒素中毒的兽药组合物、 制剂及其制备方法。
背景技术
霉菌是丝状真菌的统称, 它们往往能形成分枝繁茂的菌丝体, 但 又不像蘑菇那样产生大型的子实体; 其大致按属性可分为曲霉菌 ( Asperquillus )、 青霉菌 ( Penicillium )、 嫌孑包霉菌 ( Fusarum ) 等。 霉菌毒素则是霉菌在谷物、食品和饲料上生长繁殖过程中产生的代谢 产物, 例如镰刀菌毒素和黄曲霉毒素。 霉菌毒素通常是小分子物质, 分子量常常在几百到几千道尔顿, 并且其没有抗性, 属于热稳定性物 质, 不会因简单加热而受到破坏, 从而常常引起畜禽或人体出现霉菌 毒素中毒现象。
一种霉菌可以产生多种霉菌毒素,而同一种霉菌毒素也可以由几 种霉菌产生。 到目前为止, 已分离出几十种被公认为对畜禽和人体健 康有危害的霉菌毒素;在饲料产品中常见的且对养殖业造成严重损害 的霉菌毒素有黄曲霉毒素 ( aflatoxins , AF )、 单端孢菌毒素 ( trichothecenes ) (包括呕吐毒素和 T-2 毒素)、 玉米赤霉婦酮 ( zearalenone, ZEN ), 赭曲霉毒素 A ( ochratoxin,OT )、 烟曲霉毒素 ( fumonisins , FUM )和麦角毒素 ( ergotoxin, ERG )等。
上述几种霉菌毒素普遍存在于饲料及饲料原料中 ,对畜禽养殖和 人体健康常常会造成严重的危害, 并且带来巨大的经济损失。 由于在 畜禽养殖过程中, 畜禽对饲料的摄取是连续的, 霉菌毒素会不断被累 计, 即使是单一重量的饲料中的霉菌毒素仅仅是微量组分, 但通过一 段时间的蓄积作用同样可达到致病或致死量。
现有除去动物饲料中的霉菌毒素的方法中一般为使用传统的霉 菌毒素吸附剂或者是生物脱霉剂;前者吸附剂虽然可以吸附部分的霉 菌毒素, 但其还会吸附饲料中的营养物质; 而后者生物脱霉剂则由于 自身稳定性较差, 不耐热不耐酸等原因较难得到推广。
现有另外一种方法为采用中药复方来防止霉菌毒素引起的病变。 现有防治霉菌毒素中毒的中药复方一般为采用保肝和对肝功有恢复 作用的中药组合物, 其防治机理为: 其中的药效成分被畜禽吸收后与 畜禽已吸收进血液的霉菌毒素结合,然后将毒素运入肝脏解毒后再排 出体外; 中药复方可将已吸收入体内的霉菌毒素进行清除, 同时其药 效成分还可以有效的对抗霉菌毒素等引起的肝脏损伤等病变。 但是, 到目前为止,仍没有可以有效对霉菌毒素的中毒现象明显緩解或防治 作用的中药复方, 尤其是黄曲霉毒素导致的中毒现象。
黄曲霉毒素是目前引起畜禽霉菌毒素致病的重要原因之一,其毒 性往往较其他的霉菌毒素较大; 同时, 黄曲霉毒素致病的机理为直接 对畜禽的肝脏产生实质的病理损伤,表现为生长性能降低、 消化能力 下降、 肝酶指标升高、 氧化应激升高等, 甚至可能导致肝硬化或肝癌 变。 因此, 黄曲霉毒素对于畜禽养殖业的威胁相对其他霉菌毒素而言 较大。 发明内容
有鉴于此, 本发明提供一种防治霉菌毒素的兽药组合物, 其可以 有效改善或逆转动物霉菌毒素中毒引起的病理损伤,降低动物霉菌毒 素后的死亡率, 从而起到有效防治动物霉菌毒素中毒的作用。
为解决以上技术问题,本发明的技术方案是采用一种防治霉菌毒 素中毒的兽药组合物,所述防治霉菌毒素中毒的兽药组合物由下述中 药材制备而成, 各原料按重量份数计:
柴胡 5-8重量份; 黄芩 3-6重量份;
黄芪 4-7重量份;
泽泻 5-8重量份; 和
五味子 4-6重量份。
优选的,所述防治霉菌毒素中毒的兽药组合物由下述中药材制备 而成, 各原料按重量份数计:
柴胡 6-7重量份;
黄芩 4-5重量份;
黄芪 5-6重量份;
泽泻 6-7重量份; 和
五味子 5-6重量份。
本发明与现有技术相比, 其详细说明如下
本发明所采用的技术方案为防治霉菌毒素中毒的兽药组合物,其 由下述中药材制备而成, 各原料按重量份数计:
柴胡 5-8重量份;
黄芩 3-6重量份;
黄芪 4-7重量份;
泽泻 5-8重量份;
Figure imgf000004_0001
五味子 4-6重量份。
本发明主要采用将前述五种中药材作为原料来制备成防治霉菌 毒素的兽药组合物, 主要中药原料为柴胡、 黄芩、 黄芪、 泽泻和五味 子。
根据中兽医学理论,从辨证论治的角度分析, 畜禽霉菌毒素中毒 可以辩证为湿热下注肝胆。 湿热郁结于肝胆, 致使肝气不疏, 胆汁分 泌排泄失常,脾胃运化功能减弱,即而出现食欲不振。根据中医理论, 其治疗原则为疏肝解郁,清热利湿。因此可采用此类中药材进行配置。
本发明人以大量的中药材做研究,发现本发明所述的中药原料组 分以及含量所制备出的组合物可以很好的防治动物霉菌毒素中毒现 象, 尤其是黄曲霉毒素的中毒现象。
本发明中所使用的中药柴胡, 入肝胆经, 性善疏泄; 黄芩, 入胆 经, 长于清热燥湿; 泽泻, 利水渗湿; 黄芪, 益气健脾; 五味子, 敛 汗涩精。该五种中药原料共同制备而成的组合物可以对动物霉菌毒素 中毒现象起到较为明显的防治作用(实际效果可参见后续具体实施例 部分)。
上述中药配方中的原料以及各原料的重量份数均为在大量的实 验基础上获取的, 即使原料与本发明相同, 但各原料的重量份数若与 本发明不相同, 则其所得到的药效结果就不够理想。
进一步的,本发明优选采用所述防治霉菌毒素中毒的兽药组合物 由下述中药材制备, 各中药材按重量份计:
柴胡 6-7重量份;
黄芩 4-5重量份;
黄芪 5-6重量份;
泽泻 6-7重量份;
五味子 5-6重量份。
从后文具体实施例部分可以看出本发明进一步优选的实施方式 可对防治霉菌毒素中毒的药效有一定的提高。
本发明的第二个目的在于提供一种前述的兽药组合物在制备预 防或治疗畜禽霉菌毒素中毒的药品上的应用。
本发明前述的兽药组合物可以用于制备预防或治疗畜禽霉菌毒 素中毒的药品 ,该药品属于兽药 ,从下文的具体实施例部分可以得知 , 本发明的兽药组合物对于预防或治疗畜禽霉菌毒素中毒具有较好的 药效效果。
进一步的,本发明优选采用前述应用中可优选采用霉菌毒素为黄 曲霉毒素。 黄曲霉毒素目前是畜禽霉菌毒素中毒的首要原因, 并且, 从下文实施例部分可以得知,本发明的兽药组合物制备药品时其对于 防治黄曲霉毒素中毒的药效数据优于其他霉菌毒素的药效数据。 本发明的第三个目的在于提供一种用于防治霉菌毒素中毒的兽 药制剂, 所述兽药制剂包含有前述任一种的兽药组合物。 将前述任一 种兽药组合物制备成兽药制剂时,其制备方法可以采用现有中药兽药 制剂的常规方法,同时,其剂型也可以采用现有兽药制剂的常规制剂。
进一步的, 本发明优选采用所述兽药制剂的剂型为颗粒剂。颗粒 制剂不仅具有中药口服液分散度大、 吸收快、 作用緩和、 毒副作用低 的特点, 其药物稳定性较高。 另外, 颗粒制剂在使用时可以兌水或拌 入动物饲料, 便于规模化养殖场群体给药。 而且与口服液相比, 颗粒 制剂便于生产和贮运; 因此, 本发明优选采用所述兽药制剂的剂型为 颗粒剂。
本发明的第四个目的在于提供一种前述的防治霉菌毒素中毒的 兽药制剂的制备方法, 包含有以下步骤:
1 )将柴胡、 黄芩、 黄芪、 五味子加重量为 15-25倍的水, 煎煮 0.8-lh,过滤得水煎液,所得水煎液浓缩至相对密度为 1.21-1.25;
2 )将泽泻用乙醇浸泡 2-3h, 收集 6-8倍量的渗漉液, 流速 为 4-5mL/min; 浓缩至相对密度为 1.01-1.05;
3 )合并 1 )和 2 )所得浓缩液, 得浸膏;
4 )将 3 )所得浸膏与糖按照 1L/Ikg的体积 /质量比为 1 :3-4 的比例混合、 过筛、 干燥得所述防治霉菌毒素中毒的兽药制剂, 所述 制剂的剂型为颗粒剂。
本发明采用上述步骤来制备所述剂型为颗粒剂的兽药制剂,上述 制备方法对于所得的兽药制剂可以有效而充分的提取出各中药材中 的药效成分, 从而提高制剂的药效作用。
所述渗漉液为采用中药常规提取中的渗漉法得到, 溶剂为乙醇。 进一步的, 本发明优选采用所述步骤 1 ) 中煎煮分为两次进行, 每次 0.8-lh, 过滤后合并两次滤液得水煎液。
进一步的, 本发明优选采用所述步骤 2 ) 中泽泻为用 75%的乙醇 浸泡。 进一步的, 本发明优选采用所述制备方法包含有以下步骤:
1 )将柴胡、 黄芩、 黄芪、 五味子加重量为 20倍的水, 煎 煮两次, 每次 0.8-lh, 过滤得水煎液, 所得水煎液浓缩至相对密度为 1.21-1.25;
2 )将泽泻用 75%乙醇浸泡 3h, 收集 8倍量的渗漉液, 流速 为 4-5mL/min; 浓缩至相对密度为 1.01-1.05;
3 )合并 1 )和 2 )所得浓缩液, 得浸膏;
4 )将 3 )所得浸膏与糖按照 1L/Ikg的体积 /质量比为 1: 4的 比例混合、 过筛、 干燥得所述防治霉菌毒素中毒的兽药制剂, 所述制 剂的剂型为颗粒剂。 具体实施方式
为了使本领域的技术人员更好地理解本发明的技术方案,下面结 合具体实施例对本发明作进一步的详细说明。
对照例 1
按照以下重量份数称取各原料:
柴胡 1份
黄芩 15份
对照例 2
按照以下重量份数称取各原料:
黄芩 20份
防霉剂 10份
腐植酸钠 10份
蒙脱石 10份
大黄 20份
黄连 20份
甘草 12份
板蓝根 20份 对照例 3
按照以下重量份数称取各原料:
5份
4份
5份
4份 按照以下重量份数称取各原料:
6份
7份
8份
6份
按照以下重量份数称取各原料:
10份
2份
3份
10份
5份
按照以下重量份数称取各原料:
3份
8份
8份
2份
6份
按照以下重量份数称取各原料: 5份
3份
4份
5份
4份 以下重量份数称取各原料:
6份
7份
8份
6份 按照以下重量份数称取各原料:
5份
黄芩 6份
黄芪 4份
泽泻 5份
五味子 4份
对照例 10
按照以下重量份数称取各原料:
8份
黄芩 3份
黄芪 7份
泽泻 8份
五味子 6份
对照例 11
按照以下重量份数称取各原料: 柴胡 6份
黄芩 4份
黄芪 5份
泽泻 6份
五味子 5份
对照例 12
按照以下重量份数称取各原料:
7份
黄芩 4份
黄芪 6份
泽泻 7份
五味子 6份
对照例 13
按照以下重量份数称取各原料:
柴胡 7份
黄芩 5份
黄芪 5份
泽泻 Ί份
五味子 5份
将各对照例 1-13分别按照以下制备方法制备出相应的防治霉菌 毒素中毒的兽药组合物, 各制备方法的步骤如下:
方法( 1 ):
将对照例 1-10中所述的各中药简单粉碎并混合得兽药组合 物。
方法 ( 2 ):
1 )将对照例 7-13 中所述的柴胡、 黄芩、 黄芪、 五味子加 入重量为 15-25倍的水, 煎煮 0.8-lh, 过滤得水煎液, 所得水煎液浓 缩至相对密度为 1.21-1.25; 2 )将泽泻用 60%乙醇浸泡 2-3h, 收集 6-8倍量的渗漉液, 流速为 4-5mL/min; 所得渗漉液浓缩至相对密度为 1.01-1.05;
3 )合并 1 )和 2 ) 所得浓缩液, 得浸膏;
4 )将 3 )所得浸膏与糖按照体积 /质量比 1 :3-4的比例混合、 过筛、 干燥得所述防治霉菌毒素的兽药制剂, 所述制剂的剂型为颗粒 剂。
方法 ( 3 ):
1 )将对照例 7、 9、 11、 13 中所述的柴胡、 黄芩、 黄芪、 五味子加入重量为 20倍的水, 煎煮两次, 每次 0.8-lh, 过滤并合并 两次水煎液, 所得水煎液浓缩至相对密度为 1.21-1.25;
2 )将泽泻用 75%乙醇浸泡 3h, 收集 8倍量的渗漉液, 流 速为 4-5mL/min; 所得渗漉液浓缩至相对密度为 1.01-1.05;
3 )合并 1 )和 2 ) 所得浓缩液, 得浸膏;
4 )将 3 )所得浸膏与糖按照体积 /质量比 1 : 4的比例混合、 过筛、 干燥得所述防治霉菌毒素的兽药制剂, 所述制剂的剂型为颗粒 剂。
实施例 1——按照方法( 1 )分别制备出的对照例 1-10的兽药组 合物的药效试验
实马 方法:
1.1基础日粮 参考美国 NRC ( 1994 ) 肉用仔鸡营养需要配合成 试验饲粮, 配方及主要营养指标见表一。
表一 试验基础日粮组成和营养指标
原料 1-21 日龄 22-27日龄 营养指标 1-21 日龄 22-27日龄 玉米 56 代谢能 /(MJ kg ) 13.18 13.01 豆粕 27.3 粗蛋白 22.5 19.8 玉米蛋白粉 4 钙 0.98 0.90 鱼粉 5 磷 0.74 0.70 菜油 4 负氨酸 1.17 1.02 0.3 0.3 蛋氨酸 0.58 0.41 磷酸氢钙 1.5 1.5 蛋氨酸 +胱氨酸 0.90 0.72 石粉 1.2 1.2 赭曲霉毒素 A/^g kg 6.0 6.0 蛋氨酸 0.2 0.1
多维微量元素' " 0.5 0.5
总计 100kg
多维 量元素: 1500 IU维生素 A, 200 IU维生素 D3 , 10 mg维 生素 E, 0.5 mg维生素 K, 4 mg维生素 Bz, lO mg d-泛酸, 25 mg维 生素 B6, 25mg烟酸, 800mg氯化胆碱, 0.15mg生物素, 60mg Mn, 40 mg Zn, 80 mg Fe, 8.0 mg Cu, 0.35 mgl, 0.15 mg Se„
1.2动物分组即饲养实验
选择羽 1 日龄健康肉鸡, 购自四川正大养殖场, 按饲养试验 要求采用 2 x 2因子完全随机设计分为 12组, 分别标记为 Tl、 Τ2、 Τ3、 Τ4、 Τ5、 Τ6、 Τ7、 Τ8、 Τ9、 Τ10、 Tll、 T12共 12个实验组, 每组设 3个重复, 每个重复公母各半; 基 日粮饲喂至 7日龄, 剔除 弱小。
T12组: 8-27日龄均采用基石出日粮(不含黄曲霉毒素 B1 )喂养, T12组作为空白对照组;
T1-T10组: 8-21 日龄采用含赭曲霉毒素 A 50 g/kg的基石出日粮统 一喂养, 22 曰龄 -27 曰龄又改为基础曰粮(不含赭曲霉毒素 A ), 并 且开始投服药物, T1-T10分别按照对照例 1-10所得的兽药组合物进 行每日一次灌胃给药;
T 11组: 8-21 日龄采用含赭曲霉毒素 A 5(^g/kg的基石出日粮统一 喂养, 22日龄 -27日龄仅改为基石出日粮(不含赭曲霉毒素 A )喂养。
上述 T1-T12组均按常规进行鸡瘟、 鸡病毒性肝炎、 禽流感等疫 苗接种。 采用地面平养, 自由采食和饮水, 24h光照, 试验期 27d(l ~ 27曰龄)。
赭曲霉毒素 A的产生是用赭曲霉菌种 2471(CICC编号, 购自中国 工业微生物菌种保藏中心)按 Marquardt等的方法发酵而成。 玉米和饲 粮中赭曲霉毒素 A采用高效液相色谱法进行测定。
1.3 屠宰试验和样品采集
饲养试验结束后, 于 21、 23、 25、 27 日龄分别采样, 做动态治 疗观察。 每组选体重相近的肉鸡, 给水不给料, 禁食 12 h, 称重。 颈 静脉真空无抗凝剂采血管采血, 自然析出血清, 分装于 Eppendof管, -20°C冰箱保存。 并立即取部分肝脏组织于流式细胞仪做肝细胞凋亡 分析, 另取部分肝脏组织固定于 10%中性曱醛中, 做病理组织切片。
1.4血清生化指标分析
谷丙转氨酶 (GPT)、 谷草转氨酶 (GOT)、 碱性磷酸酶 (AKP)、 谷胱 甘肽 -S转移酶(GST )、 用南京建成生物工程研究所提供的试剂盒在 Bio-rad680酶标仪和紫外分光光度计测定。
1.5 血清抗氧化指标的测定
超氧化物歧化酶( SOD )、 谷胱甘肽过氧化物酶(GSH-PX )、 丙 二醛(MDA)采用南京建成生物工程研究所提供的试剂盒在 Bio-rad680酶标仪和紫外分光光度计测定。
1.6数据处理
试验数据处理和分析采用 SPSS(17.0)中的一般线性模式 (General Linear Models Procedure)方差分析 ,差异显著时采用 Duncan氏方法对 各组间平均数进行多重比较, PO.05表示差异显著, 结果以 ±SD表 示。
2 结 果
2.1血清生化指标
表二——碱性磷酸酶测定数据
日龄
实验组 对照例
21 23 25 27
1-T1 1 50.64±1.83 45.13±2.18* 45.28±1.82* 40.48±1.53**
1-T2 2 50.64±1.83 45.12±2.17* 45.31±1.82* 40.49±1.54** 1-T3 3 50.64±1.83 45.23±1.93* 45.36±1.78* 40.52±1.55**
1-T4 4 50.64±1.83 45.21±1.93* 45.35±1.79* 40.53±1.56**
1-T5 5 50.64±1.83 45.08±1.78* 45.09±1.83* 40.56±1.57**
1-T6 6 50.64±1.83 45.09±1.78* 45.07±1.84* 40.57±1.57**
1-T7 7 50.64±1.83 31.88±1.93** 30.87±1.82** 30.52±1.59**
1-T8 8 50.64±1.83 31.87±1.94** 30.85±1.82** 30.53±1.59**
1-T9 9 50.64±1.83 31.86±1.95** 30.86±1.82** 30.55±1.58**
1-T10 10 50.64±1.83 31.89±1.92** 30.87±1.82** 30.55±1.57**
1-Tl l 中毒 50.64±1.83 50.87±2.14 50.56±2.14 50.64±2.19
1-T12 空白 20.77±1.86** 19.84±2.19** 21.50±2.17** 21.80±1.60** 注: 同一竖排肩标 *表示与 1-T11组比较差异显著(PO.05 ); 同 一竖排肩标 **表示与 1-T11组比较差异极显著(P<0.01 )。
表三一超氧化物歧化酶测定数据
日龄
实验组 对照例
21 23 25 27
1-T1 1 27.56±3.12 29.37±2.50* 30.12±3.78* 34.19±2.80**
1-T2 2 27.56±3.12 29.38±2.51 * 30.17±3.78* 34.17±2.80**
1-T3 3 27.56±3.12 29.13±2.50* 30.25±3.69* 34.07±2.79**
1-T4 4 27.56±3.12 29.25±2.50* 30.31±3.69* 34.23±2.79**
1-T5 5 27.56±3.12 29.38±2.53* 30.23±3.80* 35.02±2.87**
1-T6 6 27.56±3.12 29.36±2.52* 30.43±3.79* 35.07±2.87**
1-T7 7 27.56±3.12 38.07±2.50** 40.17±3.89** 44.02±2.85**
1-T8 8 27.56±3.12 38.06±2.51 40.16±3.90** 44.00±2.85**
1-T9 9 27.56±3.12 38.07±2.52** 40.17±3.91 ** 44.03±2.87**
1-T10 10 27.56±3.12 38.05±2.50** 40.15±3.89** 44.04±2.87**
1-T11 中毒 27.56±3.12 27.78±2.55 28.03±3.39 27.91±3.00
1-T12 空白 35.67±0.77* 34.88±1.15 35.89±2.55 33.38±3.04 注: 同一竖排肩标 *表示与 1-Tll组比较差异显著(P<0.05 ); 同 一竖排肩标 **表示与 1-T11组比较差异极显著(P<0.01 )。
从上表二和表三的测定数据可以看出, 对照例 1-6按照制备方法 ( 1 )制备所得的防治霉菌毒素的兽药组合物的药效数据明显低于本 发明实施方式对照例 7-10按照制备方法( 1 )制备所得的防治霉菌毒 素的兽药组合物的药效数据。
实施例 2——按照方法(2 )分别制备出的对照例 7-13的兽药制 剂的药效试验
实施例 2的实验方法以及步骤同实施例 1 , 仅将实验毒素换成黄 曲霉毒素 B1 , 实验对象换成樱桃谷商品肉鸭, 购自四川绵阳樱桃谷 鸭种业公司, 从而进行相同的药效试验, 各实验组分别标记为 2-Τ1、
2-Τ2、 2-Τ3、 2-Τ4、 2-Τ5、 2-Τ6、 2-Τ7、 2-Τ8、 2-Τ9,其中, 2-T1 2-Τ7 为分别采用对照例 7-13所制得的兽药制剂的实验组, 其饲养方法同 实施例 1中 1-T1 1-T10; 2-Τ8为空白对照组, 其饲养方法同实施 例 1中 1-Τ12, 2-Τ9为中毒实验组,其饲养方法同实施例 1中的 1-Τ11。
所测定结果举例如下:
表四一谷丙转氨酶的测定数据
日龄
实验组 对照例
21 23 25 27
2-T1 7 32.05±2.75 21.65±2.50* 17.78±2.41 ** 16.65±2.50**
2-Τ2 8 32.05±2.75 21.57±2.49* 17.77±2.41 ** 16.63±2.51 **
2-Τ3 9 32.05±2.75 21.62±2.57* 17.75±2.40** 16.62±2.49**
2-Τ4 10 32.05±2.75 21.63±2.50* 17.77±2.42** 16.63±2.50**
2-Τ5 11 32.05±2.75 20.51±2.13* 16.78±2.41 ** 16.53±2.50**
2-Τ6 12 32.05±2.75 20.37±2.10* 16.71±2.41 ** 16.50±2.51 **
2-Τ7 13 32.05±2.75 20.41±2.15* 16.75±2.40** 16.51±2.50**
2-Τ8 空白 15.91±2.38** 15.38±2.65** 16.88±2.34** 16.31±2.59**
2-Τ9 中毒 32.05±2.75 32.93±3.72 35.34±2.97 31.74±2.69 注: 同一竖排肩标 *表示与 2-T9组比较差异显著(PO.05 ); 同 一竖排肩标 **表示与 2-T9组比较差异极显著( PO.01 )。
黄曲霉毒素的产生是用黄曲霉菌种 2219(CICC编号, 购自中国工 业微生物菌种保藏中心)按 Odette L. Shotwell等的方法发酵而成。玉米 和饲粮中黄曲霉毒素 B 1采用高效液相色谱法进行测定。
从上表四中可以看出, 对照例 7-13按照制备方法( 2 )制备所得 的兽药制剂对于防治霉菌毒素——黄曲霉毒素的药效测定结果中,对 照例 11-13明显高于对照例 7-10。
实施例 3—— ^照方法(3 )分别制备出的对照例 7、 9、 11、 13 的兽药制剂的药效试验
实施例 3的实验方法以及步骤同实施例 1 , 将实验毒素分别设置 成黄曲霉毒素 B1和赭曲霉毒素 A, 实验对象换成樱桃谷商品肉鸭, 购自四川绵阳樱桃谷鸭种业公司,从而进行相同的药效试验; 各实验 组分别标记为黄曲霉毒素 B1实验组: 3-Τ1、 3-Τ2、 3-Τ3、 3-Τ4、 3-Τ5、 3 -Τ6和赭曲霉毒素 Α实验组: 4-Τ1、 4-Τ2、 4-Τ3、 4-Τ4、 4-Τ5、 4-Τ6; 其中, 3-T1 3-Τ4和 4-T1 4-T4为分别采用对照例 7、 9、 11、
13 所制得的兽药制剂的实验组, 其饲养方法同实施例 1 中
1-T1 1-T10; 3-T5和 4-T5为空白对照组, 其饲养方法同实施例 1 中 1-T12; 3-T6和 4-T6为中毒实验组, 其饲养方法同实施例 1 中的 1-T11。 所测定结果举例如下:
黄曲霉毒素 B1实验组:
表五——谷丙转氨酶测定数据
日龄
实验组 对照例
21 23 25 27
3-T1 7 32.05±2.75 20.10±1.97* 17.52±1.78** 16.65±1.79**
3-Τ2 9 32.05±2.75 20.09±1.98* 17.54±1.79** 16.62±1.80**
3-Τ3 11 32.05±2.75 18.89±1.97** 16.71±1.80** 16.51±1.78**
3-Τ4 13 32.05±2.75 18.90±1.99** 16.72±1.79** 16.51±1.79** 3-T5 空白 15.91±2.38** 15.38±2.65** 16.88±2.34** 16.31±2.59**
3-T6 中毒 32.05±2.75 32.93±3.72 35.34±2.97 31.74±2.69 注: 同一竖排肩标 *表示与 3-T6组比较差异显著(PO.05 ); 同 一竖排肩标 **表示与 3-T6组比较差异极显著(PO.01 )。
赭曲霉毒素 A实验组: 表六——谷丙转氨酶测定数据
Figure imgf000017_0001
注: 同一竖排肩标 *表示与 4-T6组比较差异显著(PO.05 ); 同 一竖排肩标 **表示与 4-T6组比较差异极显著( PO.01 )。
从上表五和表六中可以看出,本发明的兽药组合物和兽药制剂对 于黄曲霉毒素的防治效果优于其他的霉菌毒素。
以上仅是本发明的优选实施方式, 应当指出的是, 上述优选实施 方式不应视为对本发明的限制,本发明的保护范围应当以权利要求所 限定的范围为准。 对于本技术领域的普通技术人员来说, 在不脱离本 发明的精神和范围内, 还可以做出若干改进和润饰, 这些改进和润饰 也应视为本发明的保护范围。
+

Claims

权 利 要 求
1、 一种防治霉菌毒素中毒的兽药组合物, 其特征在于: 所述防 治霉菌毒素中毒的兽药组合物由下述中药材制备而成,各原料按重量 份数计:
柴胡 5-8重量份;
黄芩 3-6重量份;
黄芪 4-7重量份;
泽泻 5-8重量份;
五味子 4-6重量份。
2、 根据权利要求 1所述的防治霉菌毒素中毒的兽药组合物,其 特征在于:所述防治霉菌毒素中毒的兽药组合物由下述中药材制备而 成, 各原料按重量份数计:
柴胡 6-7重量份;
黄芩 4-5重量份;
黄芪 5-6重量份;
泽泻 6-7重量份;
五味子 5-6重量份。
3、 权利要求 1-2中任一权利要求所述的兽药组合物在制备预防 或治疗畜禽霉菌毒素中毒的药品上的应用。
4、 根据权利要求 3所述的应用, 其特征在于: 所述霉菌毒素为 黄曲霉毒素。
5、 一种用于防治霉菌毒素中毒的兽药制剂, 其特征在于: 所述 兽药制剂包含有权利要求 1-2中任一权利要求所述的兽药组合物。
6、 根据权利要求 5所述的兽药制剂, 其特征在于: 所述制剂的 剂型为颗粒剂。
7、 权利要求 6所述的防治霉菌毒素中毒的兽药制剂的制备方 法, 其特征在于包含有以下步骤: 1 )将柴胡、 黄芩、 黄芪、 五味子加重量为 15-25倍的水, 煎煮 0.8-lh,过滤得水煎液,所得水煎液浓缩至相对密度为 1.21-1.25;
2 )将泽泻用乙醇浸泡 2-3h, 收集 6-8倍量的渗漉液, 流速 为 4-5mL/min; 浓缩至相对密度为 1.01-1.05;
3 )合并 1 )和 2 )所得浓缩液, 得浸膏;
4 )将 3 ) 所得浸膏与糖按照 1L/Ikg的体积 /质量比为 1 :3-4 的比例混合、 过筛、 干燥得所述防治霉菌毒素中毒的兽药制剂, 所述 制剂的剂型为颗粒剂。
8、 根据权利要求 7所述的制备方法,其特征在于:所述步骤 1 ) 中煎煮分为两次进行, 每次 0.8-lh, 过滤后合并两次滤液得水煎液。
9、 根据权利要求 7所述的制备方法,其特征在于:所述步骤 2 ) 中泽泻为用 75%的乙醇浸泡。
10、 根据权利要求 7所述的制备方法, 其特征在于包含有以下 步骤:
1 )将柴胡、 黄芩、 黄芪、 五味子加重量为 20倍的水, 煎 煮两次, 每次 0.8-lh, 过滤得水煎液, 所得水煎液浓缩至相对密度为
1.21-1.25;
2 )将泽泻用 75%乙醇浸泡 3h, 收集 8倍量的渗漉液, 流速 为 4-5mL/min; 浓缩至相对密度为 1.01-1.05;
3 )合并 1 )和 2 )所得浓缩液, 得浸膏;
4 )将 3 )所得浸膏与糖按照 1L/Ikg的体积 /质量比为 1: 4的 比例混合、 过筛、 干燥得所述防治霉菌毒素中毒的兽药制剂, 所述制 剂的剂型为颗粒剂。
+
PCT/CN2013/079981 2013-04-18 2013-07-24 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法 WO2014169542A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310136059.9A CN103169823B (zh) 2013-04-18 2013-04-18 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法
CN201310136059.9 2013-04-18

Publications (1)

Publication Number Publication Date
WO2014169542A1 true WO2014169542A1 (zh) 2014-10-23

Family

ID=48630310

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/079981 WO2014169542A1 (zh) 2013-04-18 2013-07-24 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法

Country Status (2)

Country Link
CN (1) CN103169823B (zh)
WO (1) WO2014169542A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103169823B (zh) * 2013-04-18 2014-09-24 四川农业大学 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法
CN108094681A (zh) * 2018-01-04 2018-06-01 商丘塞弗顿生物工程有限公司 一种解毒脱霉的饲料添加剂及其制备方法
CN114272311A (zh) * 2022-02-21 2022-04-05 四川农业大学 一种治疗黄曲霉毒素中毒的中兽药组合物
CN115192683A (zh) * 2022-07-07 2022-10-18 安徽科技学院 治疗/预防霉菌毒素中毒的中药组合物及其制备方法、用途

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050056A1 (en) * 1997-05-06 1998-11-12 Kemin Industries, Inc. Anti-fungal protein extracts from seeds of marigold
CN101342275A (zh) * 2008-08-25 2009-01-14 河北农业大学 一种防治鸡曲霉菌病的药物
CN101703608A (zh) * 2008-12-03 2010-05-12 泰安市山农大药业有限公司 鸡曲霉菌病防治组合物
CN102716214A (zh) * 2012-06-29 2012-10-10 河南中亚神鹏动物药业有限公司 防治霉菌毒素致病的兽药组合物
CN103006870A (zh) * 2011-09-26 2013-04-03 董根荣 一种防治禽曲霉菌病的口服液及其制备方法
CN103169823A (zh) * 2013-04-18 2013-06-26 四川农业大学 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256967C (zh) * 2003-01-30 2006-05-24 王晓 养生护肝药物及其制备方法
CN1537598A (zh) * 2003-04-20 2004-10-20 毛友昌 苁黄补肾颗粒及制备方法
CN1264503C (zh) * 2003-05-29 2006-07-19 北京汉典中西药研究开发中心 小柴胡泡腾剂的制备方法及其质量控制方法
CN101297889B (zh) * 2007-08-31 2010-09-01 天津生机集团有限公司 治疗口蹄疫的中药制剂及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050056A1 (en) * 1997-05-06 1998-11-12 Kemin Industries, Inc. Anti-fungal protein extracts from seeds of marigold
CN101342275A (zh) * 2008-08-25 2009-01-14 河北农业大学 一种防治鸡曲霉菌病的药物
CN101703608A (zh) * 2008-12-03 2010-05-12 泰安市山农大药业有限公司 鸡曲霉菌病防治组合物
CN103006870A (zh) * 2011-09-26 2013-04-03 董根荣 一种防治禽曲霉菌病的口服液及其制备方法
CN102716214A (zh) * 2012-06-29 2012-10-10 河南中亚神鹏动物药业有限公司 防治霉菌毒素致病的兽药组合物
CN103169823A (zh) * 2013-04-18 2013-06-26 四川农业大学 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LING, YUCAN: "Prevention and Treatment of Respiratory Disease of Chickens with Chinese Herbal Medicine (Continued)", LIVESTOCK AND POULTRY INDUSTRY, 2002, pages 28 - 29 *
LIU, DINGFA ET AL.: "Chinese Herbal Additives in Chicken Feed", THE LATEST DEVELOPMENT OF POULTRY STUDY-PROCEEDINGS OF 11 TH NATIONAL POULTRY SYMPOSIUM, 2003, pages 350 - 352 *
YANG, WENXIANG ET AL.: "Diagnosis and Prevention Measures of Avian Aspergillosis", TECHNICAL ADVISOR FOR ANIMAL HUSBANDRY, February 2010 (2010-02-01), pages 133 *

Also Published As

Publication number Publication date
CN103169823A (zh) 2013-06-26
CN103169823B (zh) 2014-09-24

Similar Documents

Publication Publication Date Title
CN102948641B (zh) 一种用于家禽的天然植物饲料添加剂
CN102813064A (zh) 乳仔猪用植物提取物饲料添加剂
CN102524579B (zh) 一种猪饲料中药添加剂及其制备方法和应用
CN105053637A (zh) 一种含有猪肠粘膜蛋白的仔猪配合饲料及其制备方法
US9855306B2 (en) Portulaca oleracea L. extract feed additive and preparation method thereof
CN104012807A (zh) 一种畜禽用抗病毒复合维生素预混合饲料制剂和制备方法及其应用
CN114007442A (zh) 预防非洲猪瘟及其他类似猪病或替代抗生素生长促进剂的饲料添加剂及其制备方法和应用
WO2014169542A1 (zh) 防治霉菌毒素中毒的兽药组合物、应用、制剂及制备方法
KR102012751B1 (ko) 도라지추출물 동물사료 첨가제 및 사료
CN112807348B (zh) 一种抗病促长的中药复方及其制备和应用
CN114568602A (zh) 一种提高肉鸡生长性能和机体免疫的中药复方及其制备方法和应用
CN104543576A (zh) 防治仔猪腹泻的复合植物提取物饲料添加剂及其制法应用
CN102813713B (zh) 一种绵马贯众山楂组合物、其制备方法与应用
KR20090094618A (ko) 세균성 감염증 또는 염증성 질환의 예방 또는 치료용조성물
CN111588801B (zh) 一种预防畜禽疫病的中药分散颗粒剂及其制备方法
CN103349758A (zh) 一种水产养殖动物保肝护肝的中药制剂及制备方法
CN105192430A (zh) 预防鸡疾病的鸡饲料添加剂
CN106173240A (zh) 一种肝脏保护功能复合植物提取物饲料添加剂及制备工艺
CN105748628A (zh) 一种治疗仔猪腹泻的中药可溶性粉剂
CN103768540A (zh) 一种降低血脂的中药颗粒及其制备方法
Wang et al. Phytogenic feed additives as natural antibiotic alternatives in animal health and production: A review of the literature of the last decade
CN110548079A (zh) 一种防治鸡肝病综合症的中药组合物及制备方法和应用
CN110101732A (zh) 具有改善肠道功能的菊茎叶多成分颗粒剂及其制备方法与应用
CN114652794B (zh) 一种中药组合物,中药提取物及其制备方法
Hamood et al. Effect of Terminalia chebula powder on broiler productive traits and some biochemical parameter

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13882146

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13882146

Country of ref document: EP

Kind code of ref document: A1